Ochsner Health is the leading not-for-profit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 12 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians.

Ochsner Cancer Institute (OCI) has had continuous National Cancer Institute funded research since 1983. Ochsner’s primary goal is to improve care for cancer patients in the Gulf South and to help relieve the burden of cancer for our patients. Adult and pediatric cancer patients benefit from Ochsner’s multi-disciplinary approach to cancer care delivered by a highly skilled team of physicians, oncology nurses, social workers, researchers, and other cancer professionals. Ochsner incorporates novel therapies, clinical research and comprehensive support, so that patients receive a personalized approach to treating their cancer.

The Ochsner Cancer Institute cancer research network consists of investigators across Louisiana and southern Mississippi. More than 160 cancer clinical trials are offered today at Ochsner, including NCI-sponsored studies through Ochsner’s participation in the highly successful Gulf South Clinical Trials Network with our Louisiana Cancer Research Center partner LSU Health- New Orleans. Ochsner’s clinical integration with MD Anderson Cancer Center in 2023  established Ochsner MD Anderson Cancer Center at seven locations in southeast Louisiana. This collaboration brings new cancer clinical trials and research expertise to our patients.

The Phase I clinical trial program at Ochsner has been in existence since 2016. In 2024 Ochsner became part of the National Cancer Institute Experimental Clinical Trials Network with MD Anderson and other cancer centers across the country.  

The Ochsner Cancer Institute continues work to improve the lives of cancer patients in the Gulf South by providing cancer clinical trials for those patients close to home. Ochsner is thrilled and honored to be a participating member of the Gulf South Clinical Trials Network to develop new programs for cancer prevention and treatment and reduce the burden of cancer in the region.

Contact
(504) 842-3910